Wilczek Filip, van der Stouwe Jan Gerrit, Petrasch Gloria, Niederseer David
Institute of Emergency Medicine, Stadtspital Zürich Waid, 8037 Zurich, Switzerland.
GP Practice, Sanacare Gruppenpraxis Zürich Stadelhofen, Gottfried Keller-Strasse 7, 8001 Zurich, Switzerland.
Sensors (Basel). 2025 Jan 1;25(1):187. doi: 10.3390/s25010187.
Continuous glucose monitoring (CGM) might provide immediate feedback regarding lifestyle choices such as diet and physical activity (PA). The impact of dietary habits and physical activity can be demonstrated in real time by providing continuous data on glucose levels and enhancing patient engagement and adherence to lifestyle modifications. Originally developed for diabetic patients, its use has recently been extended to a non-diabetic population to improve cardiovascular health. However, since data in this population are scarce, the effect on cardiovascular outcomes is unclear. CGM may offer potential benefits for cardiovascular prevention in healthy individuals without diabetes. The aim of this systematic review is to evaluate the use of CGM in healthy non-diabetic individuals, focusing on its potential to guide lifestyle interventions in the context of cardiovascular prevention, which may ultimately reduce cardiovascular risk.
连续血糖监测(CGM)可能会为饮食和体育活动(PA)等生活方式选择提供即时反馈。通过提供血糖水平的连续数据并增强患者对生活方式改变的参与度和依从性,可以实时证明饮食习惯和体育活动的影响。CGM最初是为糖尿病患者开发的,最近其应用已扩展到非糖尿病人群以改善心血管健康。然而,由于该人群的数据稀缺,其对心血管结局的影响尚不清楚。CGM可能为无糖尿病的健康个体的心血管预防带来潜在益处。本系统评价的目的是评估CGM在健康非糖尿病个体中的应用,重点关注其在心血管预防背景下指导生活方式干预的潜力,这最终可能降低心血管风险。